<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Barth Syndrome: Interactive Molecular Visualization</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Helvetica Neue', Arial, sans-serif;
            background: #000;
            color: #fff;
            overflow-x: hidden;
            line-height: 1.6;
        }

        .header {
            background: #000;
            border-bottom: 1px solid #333;
            padding: 2rem;
            text-align: center;
            position: sticky;
            top: 0;
            z-index: 1000;
        }

        .header h1 {
            color: #fff;
            font-size: 2.5rem;
            font-weight: 300;
            letter-spacing: 2px;
            margin-bottom: 0.5rem;
        }

        .header p {
            color: #999;
            font-size: 1rem;
            font-weight: 300;
            letter-spacing: 1px;
        }

        nav {
            background: #111;
            border-bottom: 1px solid #333;
            padding: 1rem;
            text-align: center;
            position: sticky;
            top: 120px;
            z-index: 999;
        }

        nav button {
            background: transparent;
            color: #999;
            border: 1px solid #333;
            padding: 0.7rem 1.5rem;
            margin: 0.3rem;
            cursor: pointer;
            font-size: 0.9rem;
            font-weight: 300;
            letter-spacing: 1px;
            transition: all 0.3s;
            text-transform: uppercase;
        }

        nav button:hover {
            background: #fff;
            color: #000;
            border-color: #fff;
        }

        nav button.active {
            background: #fff;
            color: #000;
            border-color: #fff;
        }

        .container {
            max-width: 1600px;
            margin: 0 auto;
            padding: 0 2rem;
        }

        .section {
            background: #000;
            padding: 3rem 0;
            min-height: 100vh;
            display: none;
            border-bottom: 1px solid #222;
        }

        .section.active {
            display: block;
        }

        h2 {
            color: #fff;
            font-size: 2rem;
            font-weight: 300;
            margin-bottom: 2rem;
            border-bottom: 1px solid #333;
            padding-bottom: 1rem;
            letter-spacing: 2px;
            text-transform: uppercase;
        }

        h3 {
            color: #fff;
            font-weight: 300;
            margin: 2rem 0 1rem 0;
            font-size: 1.5rem;
            letter-spacing: 1px;
        }

        .comparison-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 2rem;
            margin: 3rem 0;
        }

        .comparison-card {
            background: #111;
            border: 2px solid #333;
            padding: 0;
            overflow: hidden;
            transition: all 0.3s;
            cursor: pointer;
        }

        .comparison-card:hover {
            border-color: #666;
            transform: translateY(-5px);
        }

        .comparison-card.active {
            border-color: #fff;
        }

        .card-header {
            background: #000;
            padding: 1.5rem;
            border-bottom: 1px solid #333;
            text-align: center;
        }

        .card-header h3 {
            margin: 0;
            font-size: 1.2rem;
            letter-spacing: 1px;
        }

        .card-visual {
            height: 400px;
            position: relative;
            background: #0a0a0a;
            overflow: hidden;
        }

        .card-data {
            padding: 1.5rem;
            background: #111;
        }

        .data-row {
            display: flex;
            justify-content: space-between;
            padding: 0.5rem 0;
            border-bottom: 1px solid #222;
            font-size: 0.9rem;
        }

        .data-label {
            color: #999;
        }

        .data-value {
            color: #fff;
            font-weight: 400;
        }

        .data-value.good {
            color: #4CAF50;
        }

        .data-value.bad {
            color: #f44336;
        }

        .data-value.improving {
            color: #2196F3;
        }

        .visual-container {
            width: 100%;
            height: 100%;
            display: flex;
            align-items: center;
            justify-content: center;
            position: relative;
        }

        .mitochondrion {
            position: relative;
            width: 280px;
            height: 160px;
        }

        .outer-membrane {
            position: absolute;
            width: 100%;
            height: 100%;
            border: 3px solid #fff;
            border-radius: 50%;
            opacity: 0.4;
        }

        .inner-membrane {
            position: absolute;
            width: 90%;
            height: 85%;
            left: 5%;
            top: 7.5%;
            border: 2px solid #ddd;
            border-radius: 50%;
            opacity: 0.5;
        }

        .cristae-container {
            position: absolute;
            width: 80%;
            height: 70%;
            left: 10%;
            top: 15%;
        }

        .crista {
            position: absolute;
            width: 100%;
            height: 2px;
            background: #aaa;
            left: 0;
        }

        .molecule {
            position: absolute;
            width: 8px;
            height: 8px;
            border-radius: 50%;
        }

        .cardiolipin {
            background: #fff;
            box-shadow: 0 0 10px rgba(255, 255, 255, 0.5);
        }

        .mlcl {
            background: #666;
            box-shadow: 0 0 10px rgba(150, 150, 150, 0.3);
        }

        .etc-complex {
            position: absolute;
            width: 12px;
            height: 12px;
            background: #888;
            transform: rotate(45deg);
        }

        .aav-particle {
            position: absolute;
            width: 20px;
            height: 20px;
            border: 2px solid #fff;
            border-radius: 50%;
            opacity: 0.6;
        }

        .pulse {
            animation: pulse 2s ease-in-out infinite;
        }

        @keyframes pulse {
            0%, 100% { opacity: 0.3; transform: scale(1); }
            50% { opacity: 0.8; transform: scale(1.1); }
        }

        .shake {
            animation: shake 0.5s ease-in-out infinite;
        }

        @keyframes shake {
            0%, 100% { transform: translateX(0); }
            25% { transform: translateX(-2px); }
            75% { transform: translateX(2px); }
        }

        .comparison-label {
            position: absolute;
            top: 1rem;
            left: 1rem;
            background: rgba(0, 0, 0, 0.8);
            border: 1px solid #333;
            padding: 0.5rem 1rem;
            font-size: 0.8rem;
            letter-spacing: 1px;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 1px;
            background: #333;
            border: 1px solid #333;
            margin: 2rem 0;
        }

        .stat-card {
            background: #000;
            padding: 2rem;
            text-align: center;
        }

        .stat-card h3 {
            color: #fff;
            margin: 0 0 0.5rem 0;
            font-size: 1rem;
            font-weight: 300;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .stat-value {
            font-size: 2.5rem;
            font-weight: 100;
            color: #fff;
            margin: 1rem 0;
        }

        .info-box {
            background: #111;
            border: 1px solid #333;
            padding: 2rem;
            margin: 2rem 0;
            border-left: 3px solid #fff;
        }

        .pathway-container {
            background: #111;
            border: 1px solid #333;
            padding: 3rem;
            margin: 2rem 0;
        }

        .pathway-step {
            background: #000;
            border: 1px solid #333;
            padding: 1.5rem;
            margin-bottom: 1rem;
            position: relative;
            padding-left: 4rem;
        }

        .pathway-step::before {
            content: attr(data-step);
            position: absolute;
            left: 1rem;
            top: 50%;
            transform: translateY(-50%);
            width: 2rem;
            height: 2rem;
            background: #fff;
            color: #000;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: 400;
        }

        .pathway-step.highlight {
            border-left: 3px solid #fff;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            margin: 2rem 0;
            background: #111;
            border: 1px solid #333;
        }

        .data-table th {
            background: #000;
            color: #fff;
            padding: 1rem;
            text-align: left;
            font-weight: 300;
            text-transform: uppercase;
            letter-spacing: 1px;
            font-size: 0.9rem;
            border-bottom: 1px solid #333;
        }

        .data-table td {
            padding: 1rem;
            color: #999;
            border-bottom: 1px solid #222;
        }

        .data-table tr:hover {
            background: #0a0a0a;
        }

        .reference-list {
            list-style: none;
            counter-reset: reference-counter;
        }

        .reference-list li {
            counter-increment: reference-counter;
            margin-bottom: 1.5rem;
            padding-left: 3rem;
            position: relative;
            color: #999;
        }

        .reference-list li::before {
            content: counter(reference-counter);
            position: absolute;
            left: 0;
            top: 0;
            background: #111;
            border: 1px solid #333;
            width: 2rem;
            height: 2rem;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: 400;
            color: #fff;
        }

        footer {
            background: #000;
            border-top: 1px solid #333;
            padding: 2rem;
            text-align: center;
            color: #666;
            font-size: 0.9rem;
            font-weight: 300;
        }

        .reference {
            font-size: 0.8rem;
            color: #555;
            font-style: italic;
            margin-top: 0.5rem;
        }

        p, li {
            color: #999;
            font-weight: 300;
            margin-bottom: 1rem;
        }

        h4 {
            color: #ccc;
            font-weight: 400;
            margin: 1.5rem 0 0.5rem 0;
            font-size: 1.1rem;
        }

        @media (max-width: 1200px) {
            .comparison-grid {
                grid-template-columns: 1fr;
            }
        }

        @media (max-width: 768px) {
            .header h1 {
                font-size: 1.8rem;
            }
            
            .container {
                padding: 0 1rem;
            }

            nav button {
                font-size: 0.8rem;
                padding: 0.5rem 1rem;
            }
        }
    </style>
</head>
<body>
    <header class="header">
        <h1>BARTH SYNDROME</h1>
        <p>Interactive Molecular Comparison</p>
        <p style="font-size: 0.85rem; color: #666; margin-top: 1rem; letter-spacing: 1px;">Developed by Robert Nguyen</p>
    </header>

    <nav>
        <button onclick="showSection('overview')" class="active">Overview</button>
        <button onclick="showSection('comparison')">Visual Comparison</button>
        <button onclick="showSection('molecular')">Molecular Pathway</button>
        <button onclick="showSection('therapy')">Gene Therapy</button>
        <button onclick="showSection('data')">Clinical Data</button>
        <button onclick="showSection('references')">References</button>
    </nav>

    <div class="container">
        <!-- Overview Section -->
        <section id="overview" class="section active">
            <h2>Disease Overview</h2>
            
            <div class="info-box">
                <p><strong>Barth Syndrome</strong> is an X-linked recessive mitochondrial disorder caused by mutations in the TAFAZZIN gene, resulting in defective cardiolipin remodeling and subsequent mitochondrial dysfunction.</p>
            </div>

            <div class="stats-grid">
                <div class="stat-card">
                    <h3>Prevalence</h3>
                    <div class="stat-value">1:300,000</div>
                    <p>Live births (estimated)</p>
                    <p class="reference">Clarke et al., 2013</p>
                </div>
                <div class="stat-card">
                    <h3>Gene Location</h3>
                    <div class="stat-value">Xq28</div>
                    <p>X chromosome locus</p>
                    <p class="reference">Bione et al., 1996</p>
                </div>
                <div class="stat-card">
                    <h3>Protein Size</h3>
                    <div class="stat-value">292 aa</div>
                    <p>Tafazzin amino acids</p>
                    <p class="reference">NCBI Gene Database</p>
                </div>
                <div class="stat-card">
                    <h3>Mutations</h3>
                    <div class="stat-value">160+</div>
                    <p>Identified variants</p>
                    <p class="reference">BTHS Registry</p>
                </div>
            </div>

            <h3>Clinical Manifestations</h3>
            
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Prevalence</th>
                        <th>Onset</th>
                        <th>Severity</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Dilated Cardiomyopathy</td>
                        <td>70% by year 1</td>
                        <td>Infancy-Childhood</td>
                        <td>High</td>
                    </tr>
                    <tr>
                        <td>Left Ventricular Noncompaction</td>
                        <td>50%</td>
                        <td>Early</td>
                        <td>Variable</td>
                    </tr>
                    <tr>
                        <td>Neutropenia</td>
                        <td>Common</td>
                        <td>Variable</td>
                        <td>Variable</td>
                    </tr>
                    <tr>
                        <td>Skeletal Myopathy</td>
                        <td>Universal</td>
                        <td>Birth</td>
                        <td>Moderate</td>
                    </tr>
                    <tr>
                        <td>Growth Delay</td>
                        <td>Common</td>
                        <td>Childhood</td>
                        <td>Moderate</td>
                    </tr>
                </tbody>
            </table>

            <h3>Key Diagnostic Markers</h3>
            
            <div class="pathway-container">
                <div class="pathway-step" data-step="1">
                    <h4>Elevated MLCL/CL Ratio</h4>
                    <p>Normal: approximately 0.1 | Barth Syndrome: greater than 1.0</p>
                    <p class="reference">Valianpour et al., 2002</p>
                </div>
                <div class="pathway-step" data-step="2">
                    <h4>Reduced Mature Cardiolipin</h4>
                    <p>60-80% reduction in tetralinoleoyl-cardiolipin species</p>
                    <p class="reference">Schlame et al., 2003</p>
                </div>
                <div class="pathway-step" data-step="3">
                    <h4>3-Methylglutaconic Aciduria</h4>
                    <p>Elevated urinary excretion of 3-MGCA</p>
                    <p class="reference">Barth et al., 1983</p>
                </div>
            </div>
        </section>

        <!-- Visual Comparison Section -->
        <section id="comparison" class="section">
            <h2>Interactive Visual Comparison</h2>
            
            <p style="text-align: center; font-size: 1.1rem; margin-bottom: 3rem; color: #ccc;">
                Click each card to see detailed molecular differences between states
            </p>

            <div class="comparison-grid">
                <!-- Normal Cell -->
                <div class="comparison-card active" id="card-normal">
                    <div class="card-header">
                        <h3>NORMAL CELL</h3>
                        <p style="color: #4CAF50; margin-top: 0.5rem;">Functional TAZ Gene</p>
                    </div>
                    <div class="card-visual">
                        <div class="comparison-label">HEALTHY</div>
                        <div class="visual-container" id="visual-normal"></div>
                    </div>
                    <div class="card-data">
                        <div class="data-row">
                            <span class="data-label">MLCL/CL Ratio</span>
                            <span class="data-value good">0.1</span>
                        </div>
                        <div class="data-row">
                            <span class="data-label">Mature Cardiolipin</span>
                            <span class="data-value good">80%</span>
                        </div>
                        <div class="data-row">
                            <span class="data-label">Cristae Organization</span>
                            <span class="data-value good">Organized</span>
                        </div>
                        <div class="data-row">
                            <span class="data-label">ATP Production</span>
                            <span class="data-value good">100%</span>
                        </div>
                        <div class="data-row">
                            <span class="data-label">Cardiac Function (EF)</span>
                            <span class="data-value good">60%</span>
                        </div>
                    </div>
                </div>

                <!-- Barth Syndrome -->
                <div class="comparison-card" id="card-barth">
                    <div class="card-header">
                        <h3>BARTH SYNDROME</h3>
                        <p style="color: #f44336; margin-top: 0.5rem;">Mutated TAZ Gene</p>
                    </div>
                    <div class="card-visual">
                        <div class="comparison-label">DISEASED</div>
                        <div class="visual-container" id="visual-barth"></div>
                    </div>
                    <div class="card-data">
                        <div class="data-row">
                            <span class="data-label">MLCL/CL Ratio</span>
                            <span class="data-value bad">>1.0</span>
                        </div>
                        <div class="data-row">
                            <span class="data-label">Mature Cardiolipin</span>
                            <span class="data-value bad">20%</span>
                        </div>
                        <div class="data-row">
                            <span class="data-label">Cristae Organization</span>
                            <span class="data-value bad">Disorganized</span>
                        </div>
                        <div class="data-row">
                            <span class="data-label">ATP Production</span>
                            <span class="data-value bad">40%</span>
                        </div>
                        <div class="data-row">
                            <span class="data-label">Cardiac Function (EF)</span>
                            <span class="data-value bad">25%</span>
                        </div>
                    </div>
                </div>

                <!-- Gene Therapy -->
                <div class="comparison-card" id="card-therapy">
                    <div class="card-header">
                        <h3>GENE THERAPY</h3>
                        <p style="color: #2196F3; margin-top: 0.5rem;">AAV9-Delivered TAZ</p>
                    </div>
                    <div class="card-visual">
                        <div class="comparison-label">RECOVERING</div>
                        <div class="visual-container" id="visual-therapy"></div>
                    </div>
                    <div class="card-data">
                        <div class="data-row">
                            <span class="data-label">MLCL/CL Ratio</span>
                            <span class="data-value improving">0.3</span>
                        </div>
                        <div class="data-row">
                            <span class="data-label">Mature Cardiolipin</span>
                            <span class="data-value improving">70%</span>
                        </div>
                        <div class="data-row">
                            <span class="data-label">Cristae Organization</span>
                            <span class="data-value improving">Improving</span>
                        </div>
                        <div class="data-row">
                            <span class="data-label">ATP Production</span>
                            <span class="data-value improving">80%</span>
                        </div>
                        <div class="data-row">
                            <span class="data-label">Cardiac Function (EF)</span>
                            <span class="data-value improving">55%</span>
                        </div>
                    </div>
                </div>
            </div>

            <h3>Key Visual Differences</h3>
            <div class="info-box">
                <h4>Normal Cell (Healthy)</h4>
                <ul>
                    <li><strong>White molecules:</strong> Abundant mature cardiolipin (CL) properly distributed</li>
                    <li><strong>Parallel lines:</strong> Organized cristae for efficient ATP production</li>
                    <li><strong>Squares:</strong> Active electron transport chain complexes</li>
                    <li><strong>Steady state:</strong> All components working optimally</li>
                </ul>

                <h4>Barth Syndrome (Diseased)</h4>
                <ul>
                    <li><strong>Gray molecules:</strong> Excessive MLCL accumulation (dysfunctional)</li>
                    <li><strong>Few white molecules:</strong> Severe depletion of functional cardiolipin</li>
                    <li><strong>Irregular lines:</strong> Disorganized, swollen cristae</li>
                    <li><strong>Shaking animation:</strong> Indicates mitochondrial instability and dysfunction</li>
                </ul>

                <h4>Gene Therapy (Recovering)</h4>
                <ul>
                    <li><strong>Pulsing circles:</strong> AAV9 viral vectors delivering functional TAZ gene</li>
                    <li><strong>Mixed molecules:</strong> Increasing white CL, decreasing gray MLCL</li>
                    <li><strong>Improving lines:</strong> Cristae reorganizing toward normal structure</li>
                    <li><strong>Gradual recovery:</strong> ~70-80% of mitochondria successfully treated</li>
                </ul>
            </div>
        </section>

        <!-- Molecular Pathway Section -->
        <section id="molecular" class="section">
            <h2>Cardiolipin Remodeling Pathway</h2>
            
            <div class="info-box">
                <h3>Cardiolipin Structure and Function</h3>
                <p>Cardiolipin is a unique dimeric phospholipid containing four fatty acid chains attached to a glycerol bridge. In healthy cardiac tissue, approximately 85% consists of the mature tetralinoleoyl species (CL18:2)4.</p>
                <p class="reference">Schlame & Greenberg, 2017</p>
            </div>

            <div class="pathway-container">
                <div class="pathway-step" data-step="1">
                    <h4>Biosynthesis: Nascent Cardiolipin Formation</h4>
                    <p><strong>Location:</strong> Inner mitochondrial membrane, matrix-facing leaflet</p>
                    <p><strong>Enzyme:</strong> Cardiolipin synthase (CRD1)</p>
                    <p><strong>Product:</strong> Nascent cardiolipin with random acyl chain composition</p>
                    <p class="reference">Schlame et al., 2005</p>
                </div>

                <div class="pathway-step" data-step="2">
                    <h4>Deacylation: Monolysocardiolipin Formation</h4>
                    <p><strong>Enzyme:</strong> ABHD18 (α/β-hydrolase domain containing 18)</p>
                    <p><strong>Reaction:</strong> Nascent CL → MLCL + Fatty Acid</p>
                    <p><strong>Function:</strong> Removes one acyl chain to prepare for remodeling</p>
                    <p class="reference">Wang et al., 2025; Nature</p>
                </div>

                <div class="pathway-step highlight" data-step="3">
                    <h4>Reacylation: Tafazzin-Mediated Transacylation</h4>
                    <p><strong>Enzyme:</strong> Tafazzin (TAZ gene product, 33.5 kDa)</p>
                    <p><strong>Reaction:</strong> MLCL + Phosphatidylcholine → Mature CL + Lysophosphatidylcholine</p>
                    <p><strong>Specificity:</strong> Preferential transfer of linoleic acid (C18:2)</p>
                    <p><strong>Product:</strong> Tetralinoleoyl-cardiolipin (mature, functional form)</p>
                    <p><strong>DEFECT SITE IN BARTH SYNDROME</strong></p>
                    <p class="reference">Xu et al., 2006; Vreken et al., 2000</p>
                </div>

                <div class="pathway-step" data-step="4">
                    <h4>Function: Mitochondrial Membrane Integration</h4>
                    <p><strong>Mature CL localization:</strong> Inner mitochondrial membrane</p>
                    <p><strong>Protein interactions:</strong> ATP synthase (8-12 CL/complex), AAC2, cytochrome c, respiratory complexes</p>
                    <p><strong>Structural role:</strong> Maintains cristae architecture and membrane curvature</p>
                    <p class="reference">Acehan et al., 2011; Claypool et al., 2008</p>
                </div>
            </div>

            <h3>Quantitative Impact of TAZ Mutations</h3>
            
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Parameter</th>
                        <th>Normal</th>
                        <th>Barth Syndrome</th>
                        <th>Change</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Mature CL Content</td>
                        <td>80% of total CL</td>
                        <td>15-25%</td>
                        <td>-60 to -80%</td>
                    </tr>
                    <tr>
                        <td>MLCL/CL Ratio</td>
                        <td>0.1</td>
                        <td>greater than 1.0</td>
                        <td>+900%</td>
                    </tr>
                    <tr>
                        <td>Complex I Activity</td>
                        <td>100%</td>
                        <td>60-70%</td>
                        <td>-30 to -40%</td>
                    </tr>
                    <tr>
                        <td>Complex III Activity</td>
                        <td>100%</td>
                        <td>50-60%</td>
                        <td>-40 to -50%</td>
                    </tr>
                    <tr>
                        <td>Complex IV Activity</td>
                        <td>100%</td>
                        <td>65-75%</td>
                        <td>-25 to -35%</td>
                    </tr>
                    <tr>
                        <td>ATP Production</td>
                        <td>100%</td>
                        <td>30-50%</td>
                        <td>-50 to -70%</td>
                    </tr>
                    <tr>
                        <td>ROS Generation</td>
                        <td>Baseline</td>
                        <td>2-3x elevated</td>
                        <td>+100 to +200%</td>
                    </tr>
                </tbody>
            </table>
            <p class="reference">Valianpour et al., 2005; Claypool & Koehler, 2012</p>
        </section>

        <!-- Gene Therapy Section -->
        <section id="therapy" class="section">
            <h2>AAV-Mediated Gene Replacement Therapy</h2>
            
            <div class="info-box">
                <p>Gene therapy for Barth Syndrome employs Adeno-Associated Virus serotype 9 (AAV9) to deliver functional copies of the TAFAZZIN gene to cardiac and skeletal muscle tissues.</p>
            </div>

            <h3>Vector Design and Specifications</h3>
            
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Component</th>
                        <th>Specification</th>
                        <th>Rationale</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Capsid</td>
                        <td>AAV9 serotype</td>
                        <td>Natural tropism for cardiac and skeletal muscle</td>
                    </tr>
                    <tr>
                        <td>Promoter</td>
                        <td>CAG or Desmin</td>
                        <td>Strong, ubiquitous expression in target tissues</td>
                    </tr>
                    <tr>
                        <td>Transgene</td>
                        <td>Codon-optimized human TAZ</td>
                        <td>Enhanced expression efficiency</td>
                    </tr>
                    <tr>
                        <td>Size</td>
                        <td>Approximately 876 bp (TAZ coding)</td>
                        <td>Within AAV packaging limit (4.7 kb total)</td>
                    </tr>
                    <tr>
                        <td>Dose</td>
                        <td>1-5 × 10^13 vg/kg</td>
                        <td>Achieve 70%+ cardiomyocyte transduction</td>
                    </tr>
                    <tr>
                        <td>Route</td>
                        <td>Intravenous (systemic)</td>
                        <td>Broad tissue distribution</td>
                    </tr>
                </tbody>
            </table>
            <p class="reference">Wang et al., 2020; Suzuki-Hatano et al., 2019</p>

            <h3>Preclinical Efficacy Data</h3>
            
            <div class="stats-grid">
                <div class="stat-card">
                    <h3>Neonatal Survival</h3>
                    <div class="stat-value">100%</div>
                    <p>TAZ-KO mice treated at P1-2</p>
                    <p>0% survival in untreated controls</p>
                    <p class="reference">Wang et al., 2020</p>
                </div>
                <div class="stat-card">
                    <h3>Transduction Rate</h3>
                    <div class="stat-value">70-80%</div>
                    <p>Cardiomyocyte transduction</p>
                    <p>Minimum threshold for efficacy</p>
                    <p class="reference">Wang et al., 2020</p>
                </div>
                <div class="stat-card">
                    <h3>Ejection Fraction</h3>
                    <div class="stat-value">55-60%</div>
                    <p>Post-treatment cardiac function</p>
                    <p>Improved from 20-30% baseline</p>
                    <p class="reference">Suzuki-Hatano et al., 2019</p>
                </div>
                <div class="stat-card">
                    <h3>CL Restoration</h3>
                    <div class="stat-value">60-75%</div>
                    <p>Mature cardiolipin levels</p>
                    <p>Compared to wild-type</p>
                    <p class="reference">Suzuki-Hatano et al., 2019</p>
                </div>
            </div>

            <h3>Molecular Effects of Gene Therapy</h3>
            
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Parameter</th>
                        <th>Pre-Treatment</th>
                        <th>Post-Treatment</th>
                        <th>Improvement</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>MLCL/CL Ratio</td>
                        <td>greater than 1.0</td>
                        <td>0.2-0.4</td>
                        <td>Normalized (60-80%)</td>
                    </tr>
                    <tr>
                        <td>Tetralinoleoyl-CL</td>
                        <td>20% of WT</td>
                        <td>60-75% of WT</td>
                        <td>3-fold increase</td>
                    </tr>
                    <tr>
                        <td>Cristae Organization</td>
                        <td>Severely disrupted</td>
                        <td>Near-normal</td>
                        <td>Structural restoration</td>
                    </tr>
                    <tr>
                        <td>Complex I Activity</td>
                        <td>60-70%</td>
                        <td>85-95%</td>
                        <td>+25-35%</td>
                    </tr>
                    <tr>
                        <td>ATP Production</td>
                        <td>30-50%</td>
                        <td>70-85%</td>
                        <td>+40-55%</td>
                    </tr>
                    <tr>
                        <td>Cardiac Fibrosis</td>
                        <td>Moderate-Severe</td>
                        <td>Minimal</td>
                        <td>Reversal</td>
                    </tr>
                </tbody>
            </table>
            <p class="reference">Suzuki-Hatano et al., 2019; Wang et al., 2020</p>
        </section>

        <!-- Clinical Data Section -->
        <section id="data" class="section">
            <h2>Clinical and Biochemical Data</h2>
            
            <h3>Natural History Studies</h3>
            
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Study</th>
                        <th>N</th>
                        <th>Median Age at Diagnosis</th>
                        <th>5-Year Survival</th>
                        <th>Key Findings</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>French Cohort</td>
                        <td>22</td>
                        <td>3.1 weeks</td>
                        <td>51%</td>
                        <td>Cardiomyopathy in 70% by year 1; no deaths after age 3</td>
                    </tr>
                    <tr>
                        <td>BSF Registry (USA)</td>
                        <td>151</td>
                        <td>Variable</td>
                        <td>70% (improved)</td>
                        <td>Better outcomes in patients born after 2000</td>
                    </tr>
                    <tr>
                        <td>UK Series</td>
                        <td>13</td>
                        <td>Infancy</td>
                        <td>Not reported</td>
                        <td>Estimated incidence 1:140,000</td>
                    </tr>
                </tbody>
            </table>
            <p class="reference">Rigaud et al., 2013; Roberts et al., 2012; Cantlay et al., 1999</p>

            <h3>Cardiac Function Data</h3>
            
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Parameter</th>
                        <th>Normal Range</th>
                        <th>BTHS (Untreated)</th>
                        <th>BTHS (Managed)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Left Ventricular Ejection Fraction</td>
                        <td>55-70%</td>
                        <td>20-35%</td>
                        <td>35-50%</td>
                    </tr>
                    <tr>
                        <td>Left Ventricular End-Diastolic Dimension</td>
                        <td>Age-dependent</td>
                        <td>Severely increased</td>
                        <td>Moderately increased</td>
                    </tr>
                    <tr>
                        <td>Fractional Shortening</td>
                        <td>28-44%</td>
                        <td>10-20%</td>
                        <td>18-28%</td>
                    </tr>
                </tbody>
            </table>
        </section>

        <!-- References Section -->
        <section id="references" class="section">
            <h2>Scientific References</h2>
            
            <h3>Primary Research Articles</h3>
            <ul class="reference-list">
                <li>Wang, S., Li, Y., Xu, Y., Ma, Q., Lin, Z., Schlame, M., Bezzerides, V. J., Strathdee, D., & Pu, W. T. (2020). AAV gene therapy prevents and reverses heart failure in a murine knockout model of Barth syndrome. Circulation Research, 126(8), 1024-1039.</li>
                
                <li>Suzuki-Hatano, S., Saha, M., Rizzo, S. A., Witko, R. L., Gosiker, B. J., Ramanathan, M., Soustek, M. S., Jones, M. D., Kang, P. B., Byrne, B. J., Cade, W. T., & Pacak, C. A. (2019). AAV-mediated TAZ gene replacement restores mitochondrial and cardioskeletal function in Barth syndrome. Human Gene Therapy, 30(2), 139-154.</li>
                
                <li>Wang, C., Guo, Y., Wehbe, Z., Oksuz, F., Sadre, S., Wang, S., Ogut, O., & Boudina, S. (2025). Genetic suppression features ABHD18 as a Barth syndrome therapeutic target. Nature.</li>
                
                <li>Clarke, S. L., Bowron, A., Gonzalez, I. L., et al. (2013). Barth syndrome. Orphanet Journal of Rare Diseases, 8, 23.</li>
                
                <li>Rigaud, C., Lebre, A. S., Touraine, R., et al. (2013). Natural history of Barth syndrome: A national cohort study of 22 patients. Orphanet Journal of Rare Diseases, 8, 70.</li>
                
                <li>Schlame, M., & Greenberg, M. L. (2017). Cardiolipin remodeling and the function of tafazzin. Biochimica et Biophysica Acta, 1862(8), 1007-1016.</li>
                
                <li>Valianpour, F., Mitsakos, V., Schlemmer, D., et al. (2005). Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis. Journal of Lipid Research, 46, 1182-1195.</li>
                
                <li>Xu, Y., Kelley, R. I., Blanck, T. J., & Schlame, M. (2006). Remodeling of cardiolipin by phospholipid transacylation. Journal of Biological Chemistry, 281, 7363-7372.</li>
                
                <li>Bione, S., D'Adamo, P., Maestrini, E., et al. (1996). A novel X-linked gene, G4.5, is responsible for Barth syndrome. Nature Genetics, 12, 385-389.</li>
                
                <li>Claypool, S. M., & Koehler, C. M. (2012). The complexity of cardiolipin in health and disease. Trends in Biochemical Sciences, 37(1), 32-41.</li>
            </ul>
        </section>
    </div>

    <footer>
        <p>This website presents scientific information for educational purposes only.</p>
        <p>Not intended as medical advice or clinical guidance.</p>
        <p>Data current as of October 2025</p>
        <p style="margin-top: 1.5rem; color: #999;">Developed by Robert Nguyen</p>
    </footer>

    <script>
        // Navigation
        function showSection(sectionId) {
            const sections = document.querySelectorAll('.section');
            const buttons = document.querySelectorAll('nav button');
            
            sections.forEach(section => section.classList.remove('active'));
            buttons.forEach(button => button.classList.remove('active'));
            
            document.getElementById(sectionId).classList.add('active');
            event.target.classList.add('active');
        }

        // Create visual representations
        function createMitochondrion(containerId, type) {
            const container = document.getElementById(containerId);
            container.innerHTML = '';
            
            const mito = document.createElement('div');
            mito.className = 'mitochondrion';
            
            // Outer membrane
            const outer = document.createElement('div');
            outer.className = 'outer-membrane';
            if (type === 'barth') {
                outer.style.borderColor = '#666';
                outer.style.transform = 'scale(1.1)';
            }
            mito.appendChild(outer);
            
            // Inner membrane
            const inner = document.createElement('div');
            inner.className = 'inner-membrane';
            if (type === 'barth') {
                inner.style.borderColor = '#555';
            }
            mito.appendChild(inner);
            
            // Cristae
            const cristaeContainer = document.createElement('div');
            cristaeContainer.className = 'cristae-container';
            
            const cristaeCount = type === 'barth' ? 6 : 12;
            for (let i = 0; i < cristaeCount; i++) {
                const crista = document.createElement('div');
                crista.className = 'crista';
                crista.style.top = (i * (100 / cristaeCount)) + '%';
                
                if (type === 'barth') {
                    crista.style.transform = `rotate(${Math.random() * 20 - 10}deg)`;
                    crista.style.background = '#555';
                    crista.className += ' shake';
                }
                
                cristaeContainer.appendChild(crista);
            }
            mito.appendChild(cristaeContainer);
            
            // Molecules
            if (type === 'normal') {
                // Abundant cardiolipin
                for (let i = 0; i < 30; i++) {
                    const cl = document.createElement('div');
                    cl.className = 'molecule cardiolipin';
                    const angle = (i / 30) * Math.PI * 2;
                    const radius = 120;
                    cl.style.left = (140 + Math.cos(angle) * radius) + 'px';
                    cl.style.top = (80 + Math.sin(angle) * radius * 0.55) + 'px';
                    mito.appendChild(cl);
                }
            } else if (type === 'barth') {
                // Mostly MLCL
                for (let i = 0; i < 40; i++) {
                    const mlcl = document.createElement('div');
                    mlcl.className = 'molecule mlcl';
                    mlcl.style.left = (Math.random() * 250 + 15) + 'px';
                    mlcl.style.top = (Math.random() * 140 + 10) + 'px';
                    mito.appendChild(mlcl);
                }
                // Few cardiolipin
                for (let i = 0; i < 8; i++) {
                    const cl = document.createElement('div');
                    cl.className = 'molecule cardiolipin';
                    cl.style.left = (Math.random() * 200 + 40) + 'px';
                    cl.style.top = (Math.random() * 100 + 30) + 'px';
                    mito.appendChild(cl);
                }
            } else if (type === 'therapy') {
                // Mixed CL and MLCL
                for (let i = 0; i < 22; i++) {
                    const cl = document.createElement('div');
                    cl.className = 'molecule cardiolipin';
                    const angle = (i / 22) * Math.PI * 2;
                    const radius = 110;
                    cl.style.left = (140 + Math.cos(angle) * radius) + 'px';
                    cl.style.top = (80 + Math.sin(angle) * radius * 0.55) + 'px';
                    mito.appendChild(cl);
                }
                for (let i = 0; i < 15; i++) {
                    const mlcl = document.createElement('div');
                    mlcl.className = 'molecule mlcl';
                    mlcl.style.left = (Math.random() * 180 + 50) + 'px';
                    mlcl.style.top = (Math.random() * 100 + 30) + 'px';
                    mito.appendChild(mlcl);
                }
                // AAV particles
                for (let i = 0; i < 4; i++) {
                    const aav = document.createElement('div');
                    aav.className = 'aav-particle pulse';
                    aav.style.left = (Math.random() * 220 + 30) + 'px';
                    aav.style.top = (Math.random() * 120 + 20) + 'px';
                    mito.appendChild(aav);
                }
            }
            
            // ETC complexes
            const complexCount = type === 'barth' ? 4 : 8;
            for (let i = 0; i < complexCount; i++) {
                const complex = document.createElement('div');
                complex.className = 'etc-complex';
                complex.style.left = (40 + i * 30) + 'px';
                complex.style.top = '70px';
                if (type === 'barth') {
                    complex.style.opacity = '0.3';
                }
                mito.appendChild(complex);
            }
            
            container.appendChild(mito);
        }

        // Initialize visualizations
        window.addEventListener('load', () => {
            createMitochondrion('visual-normal', 'normal');
            createMitochondrion('visual-barth', 'barth');
            createMitochondrion('visual-therapy', 'therapy');
        });

        // Card interaction
        document.addEventListener('click', (e) => {
            const card = e.target.closest('.comparison-card');
            if (card) {
                document.querySelectorAll('.comparison-card').forEach(c => c.classList.remove('active'));
                card.classList.add('active');
            }
        });
    </script>
</body>
</html>
